Efficacy of Ivermectin in Outpatients With Non-severe COVID-19
Status:
Recruiting
Trial end date:
2021-05-30
Target enrollment:
Participant gender:
Summary
This is a randomized controlled trial to evaluate the efficacy of ivermectin in reducing the
risk of progression to severe disease and hospitalizations in COVID-19 patients.
Phase:
Phase 3
Details
Lead Sponsor:
Universidad Nacional de Asunción
Collaborators:
Centro de información y recursos para el desarrollo, Paraguay Centro para el Desarrollo de la Investigación Científica, CEDIC, Paraguay Consejo Nacional de Ciencias y Tecnologia, Paraguay Instituto Desarrollo, Paraguay Ministerio de Salud Pública y Bienestar Social, Paraguay